Back to O& Oppenheimer & Co Inc

NVAXNVAX

Showing 8 of 27 quarters

Position history for O&Oppenheimer & Co Inc's holdings in Novavax, Inc.

Yes. Oppenheimer holds 57,949 shares of NVAX (Novavax), worth $626,429, as of its Q3 2026 13F filing. It reduced the position by 36,810 shares (-38.8%) from Q2 2026. Oppenheimer has held NVAX since Q1 2020, across 27 quarterly 13F filings.

Current Value

$626,429

Current Shares

57,949

Total Value Change

+$276,102

Total Shares Change

+14,376

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
57,949
-38.9%
$626,4290.0%$10.81
0
2026-Q2
Decreased
94,759
-9.9%
$892,6300.0%$9.42
0
2026-Q1
Increased
105,168
+193.7%
$856,0680.0%$8.14
40
2025-Q4
Decreased
35,811
-51.6%
$240,6500.0%$6.72
0
2025-Q3
Increased
73,943
+7.9%
$641,0860.0%$8.67
26
2025-Q2
Increased
68,552
+35.1%
$431,8780.0%$6.30
31
2025-Q1
Increased
50,738
+16.4%
$325,2310.0%$6.41
27
2024-Q4
Increased
43,573
+262.7%
$350,3270.0%$8.04
38

Optional analytics helps us improve. How it’s used